RegDivergence-101: an LLM benchmark for cross-jurisdiction regulatory contradiction detection in life sciences
Read the original at arxiv.org→arXiv:2608.28607v1 Announce Type: new Abstract: Pharmaceutical sponsors developing a drug for both the United States and the European Union must reconcile guidance issued independently by the FDA and the EMA. Where...
Original headline: "RegDivergence-101: An LLM Benchmark for Cross-Jurisdiction Regulatory Contradiction Detection in Life Sciences"
Coverage timeline
- Sep 1, 04:00 UTC arXiv cs.AI lead source RegDivergence-101: An LLM Benchmark for Cross-Jurisdiction Regulatory Contradiction Detection in Life Sciences